INSP Shareholder Alert: Faruqi & Faruqi, LLP Announces That Inspire Medical Systems Investors Have Opportunity to Lead Class Action Lawsuit

The law firm Faruqi & Faruqi, LLP (based in New York) is investigating potential securities‑law claims against Inspire Medical Systems, Inc. (NYSE: INSP) and is inviting investors who purchased the company’s stock between August 6, 2024 and August 4, 2025 to contact them about serving as lead plaintiff in a class‑action lawsuit. The complaint alleges that Inspire and certain of its executives misled investors by overstating demand for its new device, the “Inspire V,” and failing to disclose significant risks regarding its launch—such as treatment‑centers lacking training and contracting, reimbursement software delays, weak demand, excess inventory, and the company’s more than 80 % reduction in its 2025 earnings guidance. On August 4, 2025, Inspire disclosed these setbacks and the company’s share price collapsed by over 32 % the next day, wiping out about US$1.2 billion in market capitalization. The notice reminds investors of the January 5, 2026 deadline to move the court to serve as lead plaintiff and notes that even investors who choose not to lead still remain class members entitled to any recovery. Investors with information about Inspire’s conduct, including whistle‑blowers, former employees or shareholders, are encouraged to reach out to the firm directly. #InspireMedical #ClassAction #SecuritiesLitigation #LeadPlaintiffOpportunity #SlimScan #GrowthStocks #CANSLIM